Back
VNET Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
53
VNET
VNET Group
Last Price:
$5.90
Seasonality Move:
0.27%
Sell
32
SRPT
Sarepta Therapeutics
Last Price:
$17.21
Seasonality Move:
17.08%
Buy
53
VNET Group (VNET)
is a Buy
Is VNET Group a Buy, Sell or Hold?
-
The current VNET Group [VNET] share price is $6.00. The Score for VNET is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
VNET is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $17.46. The Score for SRPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VNET Stock Price Chart
What is VNET Group's stock price today?
-
The VNET Group share price today is $6.00The current trend is relatively stagnant and VNET is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $17.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
VNET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 52.7 | Buy |
Chaikin Money Flow: | -1440429 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.48 - 6.1) | Buy |
Bollinger Bands (100): | (5.19 - 10.35) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.93 | Sell |
Relative Strength Index (14 RSI): | 18.78 | Sell |
Chaikin Money Flow: | -5487078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.82 - 42.04) | Sell |
Bollinger Bands (100): | (35.95 - 97.17) | Sell |
VNET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.61 | Buy |
20-day SMA: | 5.7 | Buy |
50-day SMA: | 5.85 | Buy |
200-day SMA: | 5.9 | Buy |
8-day EMA: | 5.72 | Buy |
20-day EMA: | 5.78 | Buy |
50-day EMA: | 6.18 | Sell |
200-day EMA: | 5.87 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.86 | Sell |
20-day SMA: | 32.03 | Sell |
50-day SMA: | 41.95 | Sell |
200-day SMA: | 94.84 | Sell |
8-day EMA: | 22.45 | Sell |
20-day EMA: | 29.61 | Sell |
50-day EMA: | 42.46 | Sell |
200-day EMA: | 82.86 | Sell |
VNET Group Earnings Growth & VNET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.07 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.86 per share, a decrease this year of $5.90 per share, and an increase next year of $5.54 per share.
VNET Group Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |